Business Description
eFFECTOR Therapeutics Inc
NAICS : 541714
SIC : 2834
ISIN : US28202V2079
Description
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.89 | |||||
| Equity-to-Asset | -0.28 | |||||
| Debt-to-Equity | -3.55 | |||||
| Debt-to-EBITDA | -0.63 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Book Growth Rate | 71.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 14.65 | |||||
| 9-Day RSI | 20.82 | |||||
| 14-Day RSI | 25.92 | |||||
| 6-1 Month Momentum % | -16.69 | |||||
| 12-1 Month Momentum % | 18.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.77 | |||||
| Quick Ratio | 0.77 | |||||
| Cash Ratio | 0.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -22.7 | |||||
| Shareholder Yield % | -326.69 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -150.98 | |||||
| ROIC % | -150.64 | |||||
| ROC (Joel Greenblatt) % | -11210.63 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.27 | |||||
| EV-to-Forward-EBIT | -0.72 | |||||
| EV-to-EBITDA | -0.27 | |||||
| EV-to-Forward-EBITDA | -0.72 | |||||
| EV-to-FCF | -0.29 | |||||
| Earnings Yield (Greenblatt) % | -370.37 | |||||
| FCF Yield % | -473.07 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:EFTR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
eFFECTOR Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -16.62 | ||
| Beta | 0 | ||
| Volatility % | 111.78 | ||
| 14-Day RSI | 25.92 | ||
| 14-Day ATR ($) | 1.269823 | ||
| 20-Day SMA ($) | 7.64725 | ||
| 12-1 Month Momentum % | 18.76 | ||
| 52-Week Range ($) | 1.6 - 37 | ||
| Shares Outstanding (Mil) | 3.69 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
eFFECTOR Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
eFFECTOR Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
eFFECTOR Therapeutics Inc Frequently Asked Questions
What is eFFECTOR Therapeutics Inc(EFTR)'s stock price today?
The current price of EFTR is $1.70. The 52 week high of EFTR is $37.00 and 52 week low is $1.60.
When is next earnings date of eFFECTOR Therapeutics Inc(EFTR)?
The next earnings date of eFFECTOR Therapeutics Inc(EFTR) is 2024-05-09 Est..
Does eFFECTOR Therapeutics Inc(EFTR) pay dividends? If so, how much?
eFFECTOR Therapeutics Inc(EFTR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers